We are live on ! Find out more
MBOT icon

Microbot Medical
MBOT

28 hedge funds and large institutions have $2.01M invested in Microbot Medical in 2017 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 4

8% more funds holding

Funds holding: 26 → 28 (+2)

0% less ownership

Funds ownership: 0.34% → 0.34% (-0%)

4% less capital invested

Capital invested by funds: $2.1M → $2.01M (-$91K)

29% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 7

Holders
28
Holders Change
+2
Holders Change %
+7.69%
% of All Funds
0.64%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
5
Reduced
7
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$161K
2
Citadel Advisors
Citadel Advisors
Florida
+$79.1K
3
ZCA
Zeke Capital Advisors
Pennsylvania
+$45.3K
4
UBS Group
UBS Group
Switzerland
+$11.9K
5
WS
Wedbush Securities
California
+$11.3K

Top Sellers

Rank Fund Capital Flow
1
Squarepoint
Squarepoint
New York
-$46K
2
Millennium Management
Millennium Management
New York
-$21K
3
TSS
Two Sigma Securities
New York
-$15.3K
4
Bank of New York Mellon
Bank of New York Mellon
New York
-$15K
5
Geode Capital Management
Geode Capital Management
Massachusetts
-$13.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
ASN
26
Advisory Services Network
Georgia
– +$51 +3 New
1
2

MBOT Hedge Fund Activity: Q4 2017 in Review

28 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q4 2017, worth a combined $2.01M — down 4.3% from $2.1M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new MBOT positions and 4 closed out — a net gain of 2 holders — while 5 added to existing stakes and 7 trimmed.

The largest buyer was Vanguard Group, adding an estimated $161K. The largest seller was Squarepoint, exiting entirely with an estimated $46K sold.

  • 28 institutional investors held Microbot Medical (MBOT) as of Q4 2017, up from 26 in Q3 2017.
  • Funds reported $2.01M of Microbot Medical stock for Q4 2017, down 4.3% quarter-over-quarter.
  • 6 funds opened new Microbot Medical positions in Q4 2017 and 4 closed out, a net change of +2 holders.
  • The largest Microbot Medical buyer in Q4 2017 was Vanguard Group, an estimated $161K added.
  • The largest Microbot Medical seller in Q4 2017 was Squarepoint, an estimated $46K sold.

Based on aggregated 13F filings for Q4 2017.